Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to our seven researchers who were awarded new titles in the University's 2018 Recognition of Distinction exercise.

This recognition demonstrates our staff's commitment to excellence in research and teaching and reflects the department's world-renowned multidisciplinary approach to medical research.

The recipients are:

PROFESSORS

Daniel Prieto-Alhambra“Although rewarded at a personal level, an Oxford Professor title is in my experience the result of team work. The Pharmaco- and Device Epidemiology research group at CSM-NDORMS has worked hard to become an internationally recognised unit. I will proudly hold this new title as a badge that recognises our past, current, and future work in the field of drug and medical device observational research.”

 Daniel Prieto-Alhambra, Professor of Pharmaco and Device Epidemiology 

 

Christopher Buckley

 “It is a real honour to be appointed to this post in Translational Inflammation Research. I hope it will help the Kennedy in particular and NDORMS in general lead the way in new and innovative Experimental Medicine studies with colleagues in Oxford and Birmingham”

Christopher Buckley, Professor of Translation Inflammation Research  

 

 

ASSOCIATE PROFESSORS

Sarah Snelling"I am thrilled to be recognised by the University for my research outputs, teaching and citizenship. This award is a significant milestone in my career and also reflects the support of past and present colleagues, collaborators and students."

 Sarah Snelling, Associate Professor 

 

 

John Christianson

"It is a great honour to be recognised for my academic achievements and service to the University. I owe special thanks to my students for their efforts over the years that have made our scientific research programme possible."

 John Christianson, Associate Professor

 

 

James Edwards

"I am very pleased to receive this award for the recognition of my research and that of my team, along with contributions to NDORMS and the University as a whole. I am grateful for the continued support of colleagues within the NDORMS family, and excited about our plans for the future development of Ageing studies within NDORMS."

James Edwards, Arthritis Research UK Career Development Fellow 

 

University Research Lecturers

Susan Dutton"I am delighted with this recognition by the wider academic community of the value of my work and unconventional academic path! As an applied statistician working on clinical trials with multidisciplinary teams, my role is crucial to achieving successful grant applications and trial publications, but seldom translates to Chief Investigator. It is very encouraging to have my commitment, dedication, and key contributions to successful research recognised at this level."

Susan Dutton, OCTRU Lead Statistician 

  

Gillian Farnie

“Receiving the University Research Lecturers award is a great recognition of my research and teaching achievements and also highlights how myself and my team have integrated into NDORMS since my appointment in 2016.”

Gillian Farnie, University Research Lecturer and Cellular Assays Group Leader

Similar stories

Clinical trial finds Azithromycin has no benefit against COVID-19

Main OCTRU

A clinical trial by University of Oxford researchers has confirmed that the antibiotic azithromycin has no clinical benefit in people with moderate COVID-19.

Study reveals the three most important aspects of care for hip fractures

Hip Main OCTRU Research Trauma

Older patients with hip fractures recover better if they receive treatment under the supervision of both a surgeon and a specialist in elderly care; are checked to avoid future falls; and are assessed for memory problems.

Major ERC funding awarded to Professor Michael Dustin

Awards Kennedy Main

Professor Michael Dustin and an international team of collaborators have been awarded a €10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.

The role of mAbs (neutralising monoclonal antibodies) in the fight against COVID-19

Main Research

Neutralising mAbs, a form of anti-viral medicine, are being explored as an attractive option to treat symptoms of COVID-19 and in some cases prevent infection. But what are the pros and cons of this type of treatment and what should regulators consider before granting approval?

Professor Michael Dustin elected to the National Academy of Sciences

Awards Kennedy Main

Recognised for his outstanding contributions to the field of immunology, Michael becomes the fourth Kennedy professor to be elected to the Academy.

Small mechanical forces in immune cells measured at unprecedented sensitivity

Kennedy Main Research

Oxford researchers have used advanced microscopy techniques to measure previously unseen forces generated by cells during an immune response; a breakthrough for mechanobiology and future advances in health and disease.